Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GILD crawled time : 17:00 save search
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: -63.33%
H: 263.64%
C: 127.27%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -0.12%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 3.33%
H: 0.0%
C: -2.93%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.31%
H: 0.39%
C: -0.44%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.18%
H: 0.5%
C: -0.46%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.78%
H: 5.15%
C: 2.81%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.52%
H: 0.58%
C: 0.05%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.34%
H: 1.02%
C: 0.59%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.04%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.06%
H: 0.18%
C: -1.06%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.24%
H: 2.03%
C: 1.49%
patent report global market
Gilead to Present Late Breaking Data and Real World Evidence Highlighting Key Hepatitis Indications at The Liver Meeting® 2023
Published: 2023-11-03 (Crawled : 17:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.95%
H: 0.72%
C: -0.5%
meeting hepatitis liver world
Roy Baynes, MB.Bch., M.Med., Ph.D.
Published: 2023-10-25 (Crawled : 17:00) - nurixtx.com
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: -1.08%
H: 0.0%
C: -7.61%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.31%
H: 0.89%
C: 0.62%
Global Neutropenia Market to Reach $5.77 Billion by 2028 with a CAGR of 6.2%: Growing Prevalence of Leukemia Drives Demand
Published: 2023-08-29 (Crawled : 17:00) - prnewswire.com
BAX | $40.93 -0.22% 0.0% 2.2M
|
Health Technology
|
| O: 0.48%
H: 1.4%
C: 1.15%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.27%
H: 1.29%
C: 1.24%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 0.11%
H: 1.06%
C: 1.0%
reach global growing leukemia market
Cognizant and Gilead Extend Partnership with Five-Year Service Agreement Estimated at $800 Million
Published: 2023-07-24 (Crawled : 17:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -1.02%
H: 0.45%
C: -2.71%
CTSH | $67.485 -0.42% -0.42% 4.3M
|
Technology Services
|
| O: 0.13%
H: 1.38%
C: 0.82%
partnership service cognizant agreement
Trodelvy® Continues to Show Durable Overall Survival Advantage in Pre-Treated HR+/HER2- Metastatic Breast Cancer
Published: 2023-06-05 (Crawled : 17:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.09%
H: 0.27%
C: -0.13%
trodelvy advantage breast cancer show
Kite’s Yescarta® CAR T-cell Therapy Demonstrates Significantly Longer Overall Survival Versus Standard of Care as Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma
Published: 2023-06-05 (Crawled : 17:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.09%
H: 0.27%
C: -0.13%
yescarta t-cell treatment care therapy
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -1.52%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.26%
H: 1.19%
C: 1.19%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.31%
H: 1.15%
C: 0.68%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: 0.13%
H: 0.65%
C: 0.51%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.1%
H: 0.31%
C: 0.17%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.43%
H: 1.33%
C: 0.3%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.17%
H: 1.36%
C: 1.02%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.1%
H: 0.97%
C: -0.37%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.29%
H: 2.1%
C: 1.94%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.17%
H: 1.07%
C: -0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.51%
H: 0.49%
C: -0.65%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.9%
H: 0.58%
C: 0.01%
global report growth market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA 4 | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO | $10.1 -2.6% -2.67% 250K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.7101 -1.18% -1.2% 700K
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Jounce Therapeutics earns clinical milestone payment under the CCR8 exclusive license agreement with Gilead Sciences, Inc.
Published: 2022-11-02 (Crawled : 17:00) - biospace.com/
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -1.46%
H: 2.33%
C: -0.38%
license therapeutics payment agreement milestone
Gilead Sciences Announces Collaboration With Morehouse School of Medicine and Xavier University of Louisiana College of Pharmacy to Address Inequities in HIV Care
Published: 2022-08-17 (Crawled : 17:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.54%
H: 1.4%
C: 0.08%
care sciences collaboration hiv
Gilead to Present Latest Antiviral Research and Development Data at CROI 2022 Addressing Urgent Global Needs
Published: 2022-02-08 (Crawled : 17:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.27%
H: 0.81%
C: -0.2%
research test antiviral
Cidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer, and Shane Ward as Chief Legal Officer and Corporate Secretary
Published: 2021-09-01 (Crawled : 17:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.51%
H: 1.38%
C: 1.34%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.14%
H: 0.05%
C: -1.12%
CDTX | News | $11.94 16.49% 14.15% 170K
|
Health Technology
|
| O: -0.94%
H: 2.26%
C: -2.56%
Global Acute Lymphoblastic Leukemia Treatment Market Research Report (2020 to 2025) - by Types of Cell, Therapy and Region
Published: 2021-03-24 (Crawled : 17:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.36%
H: 0.36%
C: -0.21%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.86%
H: 1.01%
C: 0.53%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 0.95%
H: 0.91%
C: -9.38%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.25%
H: 0.39%
C: 0.27%
JAZZ | $108.38 -1.18% -1.19% 400K
|
Health Technology
|
| O: 0.54%
H: 1.24%
C: -0.9%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.22%
H: 1.09%
C: -0.02%
GMAB | News | $28.47 -0.32% -0.32% 460K
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: -2.59%
TECH | $63.48 -0.33% -0.33% 980K
|
Health Technology
|
| O: 0.32%
H: 1.09%
C: -2.18%
treatment therapy leukemia research
Jounce Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
Published: 2021-03-12 (Crawled : 17:00) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: -8.22%
H: 1.57%
C: -3.77%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.95%
H: 0.16%
C: -1.49%
offering
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors
Published: 2021-01-06 (Crawled : 17:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.5%
H: 3.98%
C: 3.77%
therapy collaboration cancer blood ford research solid tumors
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.